UBS raised the firm’s price target on 3M (MMM) to $190 from $184 and keeps a Buy rating on the shares. Northrop Grumman’s existing portfolio continues to have a strong multi-year growth outlook even before considering upside potential from B-21 reconciliation and repricing, a possible F/A-XX win, and Golden Dome exposure, the analyst tells investors in a research note. The company has taken a prudently conservative outlook on these outcomes, the firm adds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMM:
- 3M price target raised to $180 from $172 at Barclays
- Wall Street Finds New Heroes as Industrial America Flexes Its Strength
- 3M Company Reports Strong Q3 2025 Financial Results
- 3M upgraded to Equal Weight from Underweight at Morgan Stanley
- Morgan Stanley upgrades 3M to Equal Weight on reset estimates